RENOVÓ
Regenerative Biologics Platform
The body already knows exactly what to do.
RENOVÓ gives it everything it needs to do it.
RENOVÓ gives it everything it needs to do it.
R
Founding Philosophy
The human body is the most complex biological system in existence — more sophisticated than anything science has yet fully mapped. It does not need to be told what to do. It needs to be given everything it requires to do it.
RENOVÓ exists at that intersection — between what the body already knows and what time has taken away. Every formulation, every protocol, every decision within this platform is made in service of one purpose: restoring the biological conditions in which the body functions at its most optimal.
Not manipulation. Not override. Restoration — of signalling factors, structural environments, cellular communication, and the biological balance that defines a body functioning as it was designed to function.
I
PhilosophyWorking With Nature.
Never Against It.
Never Against It.
The Body Knows
Aging is not a failure of the body. It is an accumulation — of depleted signalling factors, degraded structural environments, corrupted cellular communication, and the slow loss of biological balance that governed everything when the body was young.
The body's intelligence does not diminish with age. Its resources do. RENOVÓ restores those resources — not to impose a new biological state, but to return the conditions in which the body's own intelligence can express itself fully.
Restoration, Not Manipulation
There is a critical distinction between assisting the body and overriding it. RENOVÓ does not force biological processes that the body is choosing not to run. It restores what time has depleted — the signalling factors, the structural matrix, the soluble communication environment — so the body can run those processes itself.
A body returned to balance finds its own optimal expression. Our role is simply to restore the conditions for that balance to exist.
I
Restoration Over Override
Every RENOVÓ formulation is built to supply something the body produced in greater quantity earlier in life — not to force a process the body did not choose. Biology is respected as the primary authority.
II
Systems Over Ingredients
Biological outcomes are determined by how components interact within an environment. RENOVÓ does not sell ingredients. It architects complete biological systems.
III
Quality Without Exception
Source decisions are made against one written specification — donor eligibility, screening panel, and release criteria fixed in advance and documented for every lot. The source may change. The specification does not.
On Balance
Consider what happens when charge separates within a storm system — negative accumulating below, positive above, an imbalance building until the system can no longer sustain it. The lightning is not destruction. It is correction. Energy released in the precise amount required to restore equilibrium. What follows is not damage — it is a system returned to balance, functioning exactly as it was designed to.
The body operates on the same principle. RENOVÓ does not create the lightning. It restores the conditions in which the body's own correction can occur.
RENOVÓ — Founding Philosophy
II
The PlatformFive Categories.
One Complete System.
One Complete System.
I
Exosomes
Vesicle-Mediated Signalling
Membrane-bound extracellular vesicles produced from two distinct human umbilical cord starting materials — Wharton's jelly, for EXO-10, EXO-30 and EXO-50; and umbilical cord blood plasma, endothelial stem cell derived, for EXO-90 and EXO-180. Exosomes carry protected biological information — growth factors, signalling proteins, and intercellular communication — in a form the body recognises as its own. They restore signals the body once produced in abundance and has progressively lost over time.
EXO-10EXO-30EXO-50EXO-90EXO-180
Clinical & Personal Access
II
Wharton's Jelly
Structural Matrix
The connective tissue matrix of the umbilical cord. Rich in hyaluronic acid, collagen, proteoglycans, and the structural proteins that define connective tissue architecture. Wharton's Jelly restores the extracellular environment — the physical space in which cellular activity occurs. Clinical use only.
WJ-75WJ-95WJ-150WJ-300
Clinical Access Only
III
Conditioned Media
Soluble Signal Environment
The soluble secretome — the full spectrum of growth factors, cytokines, and signalling proteins secreted by umbilical cord stem cells. Conditioned media provides immediate ambient factor availability, filling the biological space the moment treatment is delivered. Clinical use only.
CM-1CM-2
Clinical Access Only
IV
Peptides
Clinical Optimisation Portfolio
RENOVÓ supplies a clinical peptide portfolio to verified provider partners. US manufactured to a minimum 99% purity specification, with Certificate of Analysis documentation on every batch. The portfolio is not listed publicly. It is disclosed in writing to approved clinical accounts, and ordering is by request against a practitioner licence.
US Manufactured99%+ PurityCOA Verified
Clinical Access Only · Provider Partners
V
Private Consulting
Personalised Protocol Design
The most complete expression of what RENOVÓ offers. A fully personalised biological optimisation protocol designed individually by Dimitri Nicholas — incorporating RENOVÓ biologics, peptides, nutritional assessment and guidance, supplement sourcing, and comprehensive functional testing through Cell Science Systems. Every protocol is built entirely around the individual. No fixed approach. No generic recommendations.
Biological ProtocolNutritional AssessmentCSS TestingSupplement Guidance
Individuals Only · Clinic Referral Available
III
Quality StandardThe Standard
Does Not Change.
Does Not Change.
Every product within the RENOVÓ platform is held to one written specification, applied without exception to every formulation, every batch, every delivery — and documented, so a clinic can verify it rather than take our word for it.
UC
Umbilical Cord Sourced
Both starting materials — Wharton's jelly and umbilical cord blood plasma — are derived exclusively from healthy, full-term C-section births within the United States. Every donor screened. Every lot traceable from source to delivery.
20+
Pathogens Screened Per Lot
Full panel screening is performed on every lot of every biological formulation, including HIV, Hepatitis, CMV, and EBV. Results are reported on that lot's Certificate of Analysis.
99%+
Purity & Verification
All peptide formulations meet a minimum 99% purity threshold. All biologics carry full Certificate of Analysis documentation. Verified on every batch without exception.
US
Source & Manufacture
All biologics sourced from healthy US donors. All peptide formulations US manufactured. Provenance documented throughout the supply chain.
IV
Source EnvironmentsSource Is Not Hierarchy.
Source Is Context.
Source Is Context.
RENOVÓ biologics are derived from two distinct starting materials of human umbilical cord origin — Wharton's jelly connective tissue matrix, and umbilical cord blood plasma. Each carries a different biological language — a different set of signals, structures, and communication patterns — making them suited to different clinical contexts.
WJ
Source Environment — I
Wharton's Jelly Derived
Perinatal connective tissue matrix from the umbilical cord. The starting material for EXO-10, EXO-30 and EXO-50, for every WJ formulation, and for the conditioned media line. Carries the biological language of structural tissue — collagen organisation, fibroblast communication, extracellular matrix interaction, and surface-level tissue repair coordination.
ES
Source Environment — II
Umbilical Cord Blood Plasma · Endothelial Stem Cell Derived
Umbilical cord blood plasma origin, endothelial stem cell derived. The starting material for EXO-90 and EXO-180. Carries the biological language of circulation — vascular interface communication, angiogenic coordination, systemic immune modulation, and neurovascular pathway signalling.
RENOVÓ's sourcing is governed by one written specification rather than by supplier preference — donor eligibility, screening panel, and release criteria set in advance and documented for every lot. All biological formulations are derived from human umbilical cord material — Wharton's jelly for the EXO-10, EXO-30, EXO-50, WJ and CM lines, and umbilical cord blood plasma for EXO-90 and EXO-180 — collected from healthy, full-term C-section births. All peptide formulations are compounded and filled in United States facilities to a minimum 99% purity specification, verified by HPLC with identity confirmed by mass spectrometry.
V
Platform ReferenceComplete Platform
At a Glance.
At a Glance.
| Product / Service | SKU | Description | Access |
|---|---|---|---|
| EXO-10Wharton's Jelly · Topical | 12.23 ±1.73B particles5mL | Lyophilised WJ-derived exosomes with 20 amino acids. Nominal designation 10 billion exosomes; the Lot 20A0021 Certificate of Analysis reports a measured particle count of 12.23 ±1.73B. Reconstituted with copper peptide solution for topical delivery. | Consumer & Clinical |
| EXO-30Wharton's Jelly · Topical | 30B exosomes5mL | Lyophilised WJ-derived exosomes with collagen peptides. Reconstituted with copper peptide solution for topical delivery. | Consumer & Clinical |
| EXO-50Wharton's Jelly · Topical & Systemic | 50B exosomes5mL | Lyophilised WJ-derived exosomes. Topical and systemic applications. Reconstituted with copper peptide solution. | Consumer & Clinical |
| EXO-90Cord Blood Plasma · Endothelial · Systemic | 90B exosomes1mL | Lyophilised exosomes from umbilical cord blood plasma, endothelial stem cell derived. Systemic administration. Longevity and healthspan applications. | Consumer & Clinical |
| EXO-180Cord Blood Plasma · Endothelial · Advanced Systemic | 180B exosomes1mL | Cryopreserved exosomes from umbilical cord blood plasma, endothelial stem cell derived. Advanced clinical systemic applications. | Clinical Only |
| WJ-75Wharton's Jelly · Structural | 75mg3mL | Frozen Wharton's Jelly at 25 mg/mL. Broad surface distribution. Lower concentration, larger area applications. | Clinical Only |
| WJ-95Wharton's Jelly · Concentrated | 95mgLyophilised | Lyophilised Wharton's Jelly; concentration set at reconstitution. Concentrated placement. Small joint applications. | Clinical Only |
| WJ-150Wharton's Jelly · High Density | 150mg1mL | Frozen Wharton's Jelly at 150 mg/mL. High density targeted placement. Structural joint applications. | Clinical Only |
| WJ-300Wharton's Jelly · Maximum Volume | 300mg2mL | Frozen Wharton's Jelly at 150 mg/mL — the same concentration as WJ-150, at double the total tissue content and double the volume. Expanded environment applications. | Clinical Only |
| CM-1Conditioned Media · Baseline | 1mLLiquid Frozen | Baseline soluble signalling environment. Immediate ambient factor availability. | Clinical Only |
| CM-2Conditioned Media · Expanded | 2mLLiquid Frozen | Expanded soluble signalling environment. Supplied alongside EXO-180 where the treating clinician elects to combine them. | Clinical Only |
| PeptidesClinical Optimisation Portfolio | By Request | Clinical peptide portfolio supplied to verified provider partners. US manufactured to a minimum 99% purity specification, COA verified on every batch. Not listed publicly; disclosed in writing on approval and ordered by request. | Clinical Only |
| Private ConsultingPersonalised Protocol Design | Bespoke | Fully personalised biological optimisation protocol including biologics, peptides, nutrition, supplements, and Cell Science Systems functional testing. | Individuals · Clinic Referral |
RENOVÓ · Regenerative Biologics Platform
The body already knows
exactly what to do.
RENOVÓ gives it everything
it needs to do it.
exactly what to do.
RENOVÓ gives it everything
it needs to do it.
Not manipulation. Not override. Restoration — of the signals, the structure, and the biological environment the body has progressively lost. Working with nature. Always.
RENOVÓ formulations are not intended to diagnose, treat, cure, or prevent any disease or health condition. All biological products are provided for regulated clinical and personal use contexts. For qualified healthcare providers and individual use only. All sourcing, testing, and quality documentation available upon request.
R
RENOVÓ
Platform Document · Foundation Reference